Herein, we focused on the P210BCR-ABL fusion gene (including two subtypes, b3a2 and b2a2), which is the most common type in patients with CML and is shared by some patients with acute lymphoblastic leukemia (ALL)[25]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.